SYK Stryker Corporation
Health Care · Health Care Equipment · close $294.66 (2026-10-16) · latest quarter in EDGAR: 2026-06-30
Stryker Corporation (SYK) has a ThetaGrade House Rating of 62/100 (grade A), ranking #4 of 150 in Health Care. Its strongest pillars are analyst sentiment (83) and profitability (72); its weakest is valuation (52). TTM revenue growth is 8.5% and operating margin 21.4%.
Data as of .
Analyst sentiment
weight 7.5% · 83| Consensus score (1–5) (3.8%) | derived | 91 |
| 90-day net rating shift (3.8%) | derived | 49 |
Growth
weight 30.83% · 60| Revenue growth YoY (TTM) (12.3%) | 8.5% | 41 |
| EPS growth YoY (TTM) (12.3%) | 27.8% | 66 |
| Revenue acceleration (6.2%) | 6.8% | 86 |
Profitability
weight 18.5% · 72| Operating margin (9.9%) | 21.4% | 75 |
| 4Q gross-margin change (8.6%) | 0.8% | 68 |
Balance sheet
weight 18.5% · 53| Net debt / EBITDA (9.9%) | 1.56× | 51 |
| Current ratio (4.9%) | 2.16 | 45 |
| Interest coverage (3.7%) | 9.12× | 69 |
Cash flow
weight 12.33% · 62| FCF margin (6.2%) | 17.1% | 64 |
| FCF yield (6.2%) | 3.8% | 60 |
Valuation
weight 12.33% · 52| P/E (inverted) (6.2%) | 30.53× | 52 |
| EV/Sales (inverted) (6.2%) | 4.80× | 53 |
Technicals (EOD)
| RSI(14) | 58.7 |
| EMA 9 / 21 | 284.81 / 283.83 · crossed up 1d ago |
| 200-day SMA | 326.64 |
| Volume vs 20d avg | 1.31× |
| 20-day return | 5.2% |
Exit-rule monitor
- WATCHTrend: close below 200-day average
Data source per metric (SEC XBRL tag or derivation): Revenue: Revenues · Gross profit: GrossProfit · Operating income: OperatingIncomeLoss · Interest expense: InterestExpenseNonoperating · D&A: DepreciationDepletionAndAmortization · EPS: EarningsPerShareDiluted · Market cap: SEC shares (dei EntityCommonStockSharesOutstanding (cover page)) × EOD close · P/E: EOD close ÷ SEC TTM EPS (EarningsPerShareDiluted).
Get rating changes like SYK's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is SYK's House Rating?
- SYK scores 62 out of 100 (grade A) as of 2026-10-16, ranking #4 of 150 Health Care stocks we cover.
- What do analysts say about SYK?
- ThetaGrade's analyst-sentiment pillar for SYK scores 83/100 against its sector peers, which we read as positive. This is our own derived score; we do not republish individual analyst ratings, counts or targets.
- When does SYK report earnings next?
- SYK's next earnings report is estimated for about 2026-10-29 (window 2026-10-26 to 2026-11-01), based on its past SEC 8-K earnings filings. This is an estimate, not a company-confirmed date.
- Is SYK a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology